Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/19/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Shelley Boyd

Wrong Dr. Shelley Boyd?

Clinician-Scientist and Assistant...

Phone: (416) ***-**** ext. ****  
St. Michael's Hospital
30 Bond St.
Toronto , Ontario M5B 1W8

Company Description: St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care...   more

Employment History

Board Memberships and Affiliations

  • Founder
    Translatum Medicus Inc.


  • MD , Ophthalmology
23 Total References
Web References
Dr. Shelley Boyd to open ..., 15 April 2014 [cached]
Dr. Shelley Boyd to open Canada's first dry age-related macular degeneration clinic at St. Michael's
Dr. Shelley Boyd tests her new confocal scanning laser ophthalmoscopy Dr. Shelley Boyd tests her new confocal scanning laser ophthalmoscopy that will allow her to provide high resolution, topographic images of the retina, the light-sensitive part of the eye where age-related macular degeneration exists. (Photo by Katie Cooper)
Dr. Shelley Boyd, an ophthalmologist and retinal specialist at St. Michael's Hospital, was instrumental in developing what has become the standard of care for the "wet" form of the disease. Dr. Boyd worked with Novartis in 2002-04 to develop Lucentis, a drug injected into the eye every four to six weeks for people with wet AMD. Dr. Boyd noted that Lucentis went from being a good idea in the lab to the standard of treatment in clinics very quickly, making it "one of the most successful knowledge translation stories you will ever hear."
Her hope is to do the same for the dry version of AMD. This spring Dr. Boyd will open the first dedicated high-risk dry AMD clinic in Canada. She recently acquired an imaging device known as a confocal scanning laser ophthalmoscope that will allow her to provide high-resolution, topographic images of the macula . With this device she can better evaluate a patient's risk of disease progression and describe the various subtypes of the disease.
For more information, or to arrange an interview with Dr. Boyd, contact:
WHO | Translatum Medicus Inc - TMi Dr Shelley Boyd, 2 May 2014 [cached]
Translatum Medicus Inc. was founded by Dr Shelley Boyd, an Ophthalmologist specializing in diseases of the retina, and scientist at St Michael's Hospital. She is an Assistant Professor in the Departments of Ophthalmology & Vision Sciences, and Adjunct Assistant Professor in the Department of Laboratory Medicine & Pathobiology, University of Toronto, and Biomedical Engineering, McMaster University, Hamilton.
In addition to her focus on science and medicine, Dr Boyd was formerly Head of the Ocular Angiogenesis Research Program worldwide for Novartis Pharmaceuticals, Switzerland, and helped bring today's treatment for wet AMD to patients around the globe.
Dr Boyd uniquely aligns her knowledge of science, medicine and the pharmaceutical industry, and combines this with her passion for patient care. She is Founding Director of the "High Risk Dry AMD Clinic" at St Michael's Hospital, Toronto, and the Ophthalmology Patient Education & Research Centre (Eye-PERC).
Dr Shelley Boyd opens Canada's first dedicated dry AMD clinic at St Michael's Hospital
One of my clients, Translatum ..., 1 Oct 2015 [cached]
One of my clients, Translatum Medicus Inc., led by its President, Dr. Shelley Boyd (who is herself a retina specialist who runs Canada's only dedicated high risk dry age-related macular degeneration (dry AMD) clinic), is developing a treatment for dry AMD. While new treatments have transformed lives for people with wet AMD, the remaining 85% of patients with AMD have the dry form. And there is no treatment. In fact, AMD is referred to as a "time bomb of vision loss" by the American Academy of Ophthalmology. I'm fortunate to be able to work closely with Dr. Boyd to assist her with her vision of transforming lives not only in Canada, but around the world!
Network Researchers, 16 June 2011 [cached]
Shelley Boyd
Ophthalmology and Vision Sciences, University of Toronto
Shelley Boyd is an Assistant Professor in the Department of Ophthalmology and Vision Sciences at the University of Toronto. After graduate training in Molecular Neurobiology, she studied Medicine, and is a Fellow of the Royal College of Surgeons of Canada, with specialization in Ophthalmology. She has three Fellowships in Medical Retina, Ocular Pathology, and Cell Biology (Angiogenesis) - the first two from University College London, UK, and the latter from the Scripps Research Institute, California. After less than one year in academia, she accepted the position of Disease Expert with the Novartis Institute of Biomedical Research (NIBR), Basel, Switzerland, where she was Director, world-wide, of the ophthalmology pre-clinical ocular angiogenesis division. She was also head of the NIBR ophthalmology translational program where she was responsible for strategic planning, and importantly, for ensuring that the pre-clinical models and the methodologies used to study them were directly relevant and aligned with clinically available outcome measures. Having returned to the University of Toronto three years ago, she dedicates over 90% of her time to basic research, where she focuses on transgenic models of diabetic retinopathy, acute retinal neurodegeneration, and retinal stem cells. She is currently Founding Director of Toronto's adult Visual Electrophysiology Unit, and within these three years has obtained over $4 million of funding from the CIHR, CHRP (Canadian Health Research Program), the Juvenile Diabetes Research Fund, the Canadian Diabetes Association, and several others.
Other People with the name "Boyd":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.